| Industrial Conglomerates Industry | Industrials Sector | Mr. Xuemin Wang CEO | XSHE Exchange | CNE100001XS7 ISIN |
| CN Country | 1,821 Employees | 20 May 2025 Last Dividend | 23 May 2018 Last Split | - IPO Date |
Dirui Industrial Co.,Ltd. is a leading entity in the medical inspection products sector, primarily serving the People's Republic of China. Since its inception in 1992, the company has been devoted to the research and development, manufacturing, and marketing of an extensive array of medical instruments and corresponding test strip reagents. Situated in Changchun, Dirui has firmly established its position in the healthcare industry by consistently offering innovative solutions designed to enhance diagnostic processes and patient care.
This includes the development and supply of equipment and reagents for the analysis of urine. These products are designed for the accurate detection and quantification of various biomarkers in urine samples, aiding in the diagnosis and monitoring of kidney diseases, urinary tract infections, and other conditions.
Dirui provides a range of instruments and reagents for biochemical analysis. These tools are crucial for the measurement of chemical constituents in blood and other body fluids, offering essential insights into the metabolic state of an individual and contributing to the diagnosis of numerous diseases.
The company's chemiluminescence immunoassay products leverage advanced technology for the detection of specific antigens or antibodies in blood samples. This method is highly sensitive and specific, making it ideal for early disease detection, including hormonal disorders and infectious diseases.
Specializing in the analysis of gynecological secretions, Dirui offers innovative solutions that help in diagnosing infections and conditions affecting the female reproductive system. These products aim to provide accurate, reliable results for better gynecological health management.
Dirui's blood cell analysis products are designed for the quantitative and qualitative evaluation of blood cells. These products are essential for diagnosing and monitoring blood disorders, such as anemia and leukemias, by providing detailed information on blood cell count and morphology.
The coagulation analysis products by Dirui include devices and reagents for assessing the blood's clotting ability. These are critical in diagnosing bleeding disorders, managing anticoagulant therapy, and screening for clotting risks before surgical procedures.
Dirui also offers integrated laboratory solutions that combine multiple diagnostic technologies and methods. These comprehensive systems are designed to enhance the efficiency and effectiveness of laboratory operations, enabling the simultaneous performance of a wide range of analyses.